| J9271 | Injection, pembrolizumab, 1 mg | 16,600 | $40 | $630.8K |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 20,700 | $20 | $351.9K |
| J0897 | Injection, denosumab, 1 mg | 6,720 | $20 | $127.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 320 | $140 | $43.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 250 | $110 | $27.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 230 | $100 | $22K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 320 | $50 | $17.4K |
| J1750 | Injection, iron dextran, 50 mg | 1,280 | $10 | $16.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 70 | $60 | $4.6K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 20 | $170 | $4K |